Ikarian Capital’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-361,518
| Closed | -$430K | – | 90 |
|
|
2022
Q3 | $430K | Sell |
361,518
-60,821
| -14% | -$72.3K | 0.09% | 51 |
|
|
2022
Q2 | $761K | Sell |
422,339
-350,000
| -45% | -$631K | 0.14% | 52 |
|
|
2022
Q1 | $1.56M | Sell |
772,339
-340,330
| -31% | -$688K | 0.21% | 49 |
|
|
2021
Q4 | $3.02M | Hold |
1,112,669
| – | – | 0.45% | 30 |
|
|
2021
Q3 | $4.96M | Sell |
1,112,669
-16,804
| -1% | -$75K | 0.35% | 23 |
|
|
2021
Q2 | $6.55M | Buy |
1,129,473
+450,000
| +66% | +$2.61M | 0.53% | 23 |
|
|
2021
Q1 | $4.77M | Buy |
679,473
+37,365
| +6% | +$262K | 0.16% | 43 |
|
|
2020
Q4 | $3.08M | Sell |
642,108
-114,128
| -15% | -$548K | 0.14% | 56 |
|
|
2020
Q3 | $4.41M | Buy |
756,236
+741,318
| +4,969% | +$4.32M | 0.32% | 28 |
|
|
2020
Q2 | $101K | Sell |
14,918
-397,000
| -96% | -$2.69M | 0.01% | 77 |
|
|
2020
Q1 | $2.62M | Buy |
+411,918
| New | +$2.62M | 0.2% | 32 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 84 |
|